Artificial Intelligence Driven Innovation: Advancing Mesenchymal Stem Cell Therapies and Intelligent Biomaterials for Regenerative Medicine
Mengyu Huang, Waruna Lakmal Dissanayaka, Cynthia K Y Yiu, Huang Chun-Yuh, Stuart Goodman · 2025
Read Artificial Intelligence Driven Innovation: Advancing Mesenchymal Stem Cell Therapies and Intelligent Biomaterials for Regenerative Medicine by Mengyu Huang, Waruna Lakmal Dissanayaka, Cynthia K Y Yiu, Huang Chun-Yuh, Stuart Goodman (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12729526.txt.
Description
Artificial intelligence (AI) is revolutionizing regenerative medicine, particularly in advancing mesenchymal stem cell (MSC) therapies and smart biomaterials. This review highlights AI’s role in two core areas: First, at the biological level, AI can be used to predict MSC differentiation, immunomodulatory function, and therapeutic potential by analyzing multi-omics and imaging data, deciphering heterogeneity and improving precision.
Catalog record
| CREATOR | Mengyu Huang, Waruna Lakmal Dissanayaka, Cynthia K Y Yiu, Huang Chun-Yuh, Stuart Goodman |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 69 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |